Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy

Background Enhanced glucose metabolism has been reported in many cancers. Glucose-6-phosphate dehydrogenase (G6PD) is a rate-limiting enzyme involved in the pentose phosphate pathway, which maintains NADPH levels and protects cells from oxidative damage. We recently found that low G6PD expression co...

Descripció completa

Dades bibliogràfiques

Autors principals:	Akimichi Morita, Hiroshi Kato, Motoki Nakamura, Maki Yoshimitsu, Tetsuya Magara, Katsuhiro Okuda, Keisuke Yokota, Shinji Kano
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2024-07-01
Col·lecció:	Journal for ImmunoTherapy of Cancer
Accés en línia:	https://jitc.bmj.com/content/12/7/e008441.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!